Alhallak, K.; Sun, J.; Jeske, A.; Park, C.; Yavner, J.; Bash, H.; Lubben, B.; Adebayo, O.; Khaskiah, A.; Azab, A.K.
Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges. Cancers 2021, 13, 2853.
https://doi.org/10.3390/cancers13122853
AMA Style
Alhallak K, Sun J, Jeske A, Park C, Yavner J, Bash H, Lubben B, Adebayo O, Khaskiah A, Azab AK.
Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges. Cancers. 2021; 13(12):2853.
https://doi.org/10.3390/cancers13122853
Chicago/Turabian Style
Alhallak, Kinan, Jennifer Sun, Amanda Jeske, Chaelee Park, Jessica Yavner, Hannah Bash, Berit Lubben, Ola Adebayo, Ayah Khaskiah, and Abdel Kareem Azab.
2021. "Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges" Cancers 13, no. 12: 2853.
https://doi.org/10.3390/cancers13122853
APA Style
Alhallak, K., Sun, J., Jeske, A., Park, C., Yavner, J., Bash, H., Lubben, B., Adebayo, O., Khaskiah, A., & Azab, A. K.
(2021). Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges. Cancers, 13(12), 2853.
https://doi.org/10.3390/cancers13122853